欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0341/001
药品名称Premovir
活性成分
    • brivudine 125.0 mg
剂型Tablet
上市许可持有人Berlin-Chemie AG Glienicker Weg 125 D-12489 Berlin
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Luxembourg (LU)
    • Austria (AT)
      Mevir 125 mg-Tabletten
    • Spain (ES)
      Nervinex 125 mg comprimidos
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
许可日期2002/03/05
最近更新日期2023/11/29
药物ATC编码
    • J05A DIRECT ACTING ANTIVIRALS
    • J ANTIINFECTIVES FOR SYSTEMIC USE
    • J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
    • J05 ANTIVIRALS FOR SYSTEMIC USE
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase